Pharmacist's Letter | CE & Recommendations You Can Trust

October 2023 Issue

Be Ready for Updated mRNA COVID-19 Vaccines

It’ll be all hands on deck for 2023-2024 COVID-19 vaccines...

Resources

FAQ: Flu Vaccines for 2023-24
Chart: Comparison of Pneumococcal Vaccines
Chart: COVID-19 Vaccines

Educate About Nirsevimab to Prevent RSV

You’ll hear buzz about nirsevimab-alip (Beyfortus) to prevent respiratory syncytial virus (RSV) in young children...

Think of the “ABCDS” When Managing Chronic Coronary Disease

You’ll get questions about managing chronic coronary disease...

Help Prevent Errors with Transplant Meds

You can help ensure safe transitions of care for patients after discharge on transplant meds...

GO TO FULL ISSUE

CE & Training

Podcast: RSV Vaccines in Older Adults

CE-in-the-Letter: Pharmacist's Letter October 2023

Live CE: Pharmacy Essential Updates October 2023

Self Study CE: Non-Opioid Pain Management

GO TO CE & TRAINING ORGANIZER >

Free Clinical Resources

Drugs for Type 2 Diabetes

COVID-19 Treatments of Interest

Equianalgesic Dosing of Opioids for Pain Management

GO TO ALL CLINICAL RESOURCES >

What is Pharmacist’s Letter?

Pharmacist's Letter is the resource trusted by over 200,000 pharmacists for staying current on medication recommendations and taking and tracking CE. Learn more >

Developing Your Pharmacy Career

Pharmacist's Letter is one of many CE and training solutions from TRC Healthcare. We support pharmacists like you at all stages of their career. Learn more about:

Solutions for Hospital Pharmacists

Advanced Resources for Natural Medicines

Training on Cannabis for Pharmacists